Ms. magazine  -- more than a magazine a movement

SIGN UP FOR MS. DIGEST, JOBS, NEWS AND ALERTS

FEMINIST WIRE NEWSBRIEFS

ABOUT
SEE CURRENT ISSUE
SHOP MS. STORE
MS. IN THE CLASSROOM
FEMINIST DAILY WIRE
FEMINIST RESOURCES
PRESS
JOBS AT MS.
READ BACK ISSUES
CONTACT
RSS (XML)
 
feminist wire | daily newsbriefs

April-21-03

Request Filed for Over-the-Counter Emergency Contraception

Women's Capital Corporation, makers of the emergency contraceptive Plan B, submitted their request to the Food and Drug Administration (FDA) today to make Plan B available over the counter. The FDA is expected to make a decision in about 10 months, according to the Washington Post.

“The United States has the highest rate of unintended pregnancies in the industrialized world,” said Beth Jordan, MD, medical director of the Feminist Majority Foundation. “Since emergency contraception has the potential to prevent half of these pregnancies, the scientific imperative is clear: emergency contraception must be available over the counter.” Emergency contraception can prevent pregnancy for up to 72 hours after unprotected sex, failed contraception, or rape. It is safer than aspirin, meets all of the FDA’s requirements for over the counter status, and is up to 95% effective if used within the first 24 hours. Emergency contraception has the potential to prevent 800,000 abortions in the United States annually.

Although emergency contraception is currently available with a prescription, many women face significant obstacles in obtaining it. Women at James Madison University in Virginia, for example, can no longer access emergency contraception at the campus health center, according to the Associated Press. The university’s board of visitors voted to stop dispensing emergency contraception after receiving a complaint from a state delegate.

“Emergency contraception is very time sensitive,” stated Dr. Jordan. “Women must be able to access emergency contraception immediately after unprotected sex. Emergency contraception’s unwarranted prescription status prevents women from doing so.”

TAKE ACTION Tell the FDA to make emergency contraception available over the counter.

Media Resources: Washington Post 4/21/03; Associated Press 4/19/03


© Feminist Majority Foundation, publisher of Ms. magazine

If you liked this story, consider making a tax-deductible donation to support Ms. magazine.

 

 

Send to a Friend
Their
Your
Comments
(optional)


More Feminist News

1/27/2016 Study Exposes 'Gender Gap' in Media Coverage of Reproductive Issues - A new study by the Women's Media Center has revealed more than half of news stories focusing on reproductive issues are written by men. According to WMC Media Watch: the Gender Gap in Coverage of Reproductive Issues, men penned 52 percent of bylines discussing issues of reproductive health care - including contraception and abortion - compared to just 37 percent by women. . . .
 
1/27/2016 Taiwan Elects First Woman President - In a landslide victory, the leader of Taiwan's Democratic Progressive Party (DPP) Tsai Ing-wen won the country's presidential election, becoming the first woman in Taiwan's history to hold the position. Emphasizing her party's commitment to maintaining Taiwan's independence from China, Tsai won over young voters eager to usher in a political changing of the guard following some 70 years of dominance by the pro-Chinese unification party, the Kuomintang (KMT), chaired by presidential opponent Eric Chu. . . .
 
1/26/2016 Anti-Abortion Extremists Behind Planned Parenthood Attack Videos Indicted - Two anti-abortion extremists responsible for last year's misleading videos attacking Planned Parenthood have been indicted on criminal charges by a grand jury in Houston, Texas. On Monday, Harris County district attorney Devon Anderson announced that David Daleiden, the director of the Center for Medical Progress (CMP) - the group behind deceptive videos falsely accusing Planned Parenthood of illegally selling fetal tissue - was indicted on a felony charge of tampering with a governmental record and on a misdemeanor charge related to the purchasing of human organs. . . .